In vitro drug release mechanism from lipid nanocapsules (LNC).
Lipid nanocapsules are recently developed lipid nanocarriers for delivery of lipophilic drugs. Due to their small size and biocompatible nature, lipid nanocapsules (LNC) may be promising carriers for drug delivery with different routes of administration. The aim of this work was to study the effect of formulation variables on the in vitro drug release from LNC. Ibuprofen as a model drug was entrapped in the oily core while Cremophor A25 and Cremophor A6 were used as hydrophilic surfactants in different ratios ranging from 1:1 to 1:0. All the prepared LNC were of comparable particle sizes around 50nm. Varying Cremophor compositions as well as the presence of lecithin, cetyl or stearyl alcohol had no significant effect on the in vitro drug release profiles. However, drug release rates increased significantly with increasing the temperature from 4 to 50 degrees C, i.e. the flux increased from 1.5 to 7microg/(cm(2)min). This was explained by the increased ibuprofen-lipid interactions at reduced temperature where the increased viscosity of the lipid significantly slows down the drug diffusion to the external aqueous phase. In summary, the physicochemical properties of the drug as well as the oil phase have a high impact on the drug release rate while the surfactant type, composition or density exerted only a minor effect.
Abdel-Mottaleb
Mona M A
MM
Laboratory of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Bonn, Germany.
Neumann
Dirk
D
Lamprecht
Alf
A
D002152:Calorimetry, Differential Scanning; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004337:Drug Carriers / Q000138:chemical synthesis / Q000737:chemistry / Q000493:pharmacokinetics*; D007052:Ibuprofen / Q000737:chemistry / Q000493:pharmacokinetics*; D007700:Kinetics; D053769:Nanocapsules; D011092:Polyethylene Glycols / Q000737:chemistry*; D012995:Solubility; D014783:Viscosity
D004337:Drug Carriers; D053769:Nanocapsules; D011092:Polyethylene Glycols; C009314:polyethylene glycol monostearate; D007052:Ibuprofen